A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma
2022 · BMC Cancer · 12 citations
https://doi.org/10.1186/s12885-022-09625-x
S
Satoshi Moriya
Nihon University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
587
Citations
14
h-index
19
i10-index
Satoshi Moriya is an academic researcher from Nihon University. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Pancreatic and Hepatic Oncology Research & Liver Disease Diagnosis and Treatment. The author has an h-index of 14, co-authored 45 publications.
Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat